[1]
2023. Evaluation of bleeding duration and risk between different dual antiplatelet strategies administered after percutaneous coronary intervention: a scoping review. Research, Society and Development. 12, 8 (Aug. 2023), e7112842867. DOI:https://doi.org/10.33448/rsd-v12i8.42867.